Skip to main content
NIH funding notice RFA-HD-18-102

Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44)

Closed on January 22, 2018.

Posted
November 22, 2017
Close date
January 22, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $224,934 in first-year total cost, median $224,934.

Most frequent study sections

  1. Special Emphasis Panel[ZHD1 DSR-K (51)]1

Most frequent institutions

  1. MUCOMMUNE, LLC1
Competing awards under RFA-HD-18-102 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Capsule-intravaginal ring for sustained release of antibodies for non-hormonal contraception and vaginal protection against HIV1R44HD097063-01CONE, RICHARDMUCOMMUNE, LLC, NC$224,934ZHD1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.